Web Results

www.pacermonitor.com/public/case/22703211/Williams_v_Bayer_Healthcare_Pharmaceuticals,_Inc_et_al

Oct 11, 2017 ... Williams v. Bayer Healthcare Pharmaceuticals, Inc. et al (1:17-cv-07816), New York Southern District Court, Filed: 10/11/2017 - PacerMonitor ...

dockets.justia.com/docket/new-york/nysdce/1:2017cv07877/482138

6 days ago ... Other case filed on October 13, 2017 in the New York Southern District Court.

www.jpml.uscourts.gov/sites/jpml/files/Hearing_Order-3-30-2017.pdf

Mar 30, 2017 ... District of Mississippi: Northern District of Alabama. BRIDGES, ET AL. v. BAYER HEALTHCARE PHARMACEUTICALS, INC., ET AL.,. C.A. No.

caselaw.findlaw.com/us-8th-circuit/1687096.html

Dec 17, 2014 ... Case opinion for US 8th Circuit TOWNSEND v. Bayer HealthCare Pharmaceuticals Inc., Defendant–Appellant.. Read the Court's full decision ...

www.lfcj.com/uploads/3/8/0/5/38050985/third_party_funding_motion_to_compel.pdf

Attorneys for Defendants Bayer HealthCare Pharmaceuticals Inc. and. Janssen ... NastLaw LLC Mark A. Hoffman, Esquire. 1 101 Market Street, ... Ann Espersen and Charles Espersen V. Janssen Pharmaceuticals, Inc., et al., Jan. 2016, No.

onlinelibrary.ectrims-congress.eu/ectrims/2016/32nd/146560/jerome.de.seze.infusion-related.reactions.with.ocrelizumab.in.relapsing.html?f=m3s440719

Results: Safety analyses included 825 OCR- vs 826 IFNβ-1a‒treated patients ... Almiral, Bayer, Biogen, Chugai, CSL Behring, F. Hoffmann-La Roche Ltd., Genzyme, ... Gavin Giovannoni has received honoraria from AbbVie, Bayer HealthCare, ... Almirall, Bayer Health Care Pharmaceuticals, CLC Behring, Genentech, Inc., ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC3355879

Nov 16, 2011 ... This remains a major challenge (Gonzalez-Angulo et al., 2007) and it is ... its specific and superior tubulin targeting activity (Hoffmann et al., ..... synthesized at Bayer Healthcare Pharmaceuticals (Berlin, Germany) through total syntheses. .... h with 0.076 μL DharmaFECT® 2 (Dharmacon, Inc., Lafayette, CO, ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4117366

The 1996 vs 2013 multiple sclerosis phenotype descriptions for relapsing disease ..... boards/DSMB: Bayer HealthCare Pharmaceuticals, Biogen Idec, EMD Serono, Inc., Novartis, ... Genentech, F. Hoffmann-LaRoche, Ironwood Pharmaceuticals Inc., ISIS Pharmaceuticals Inc., .... Kappos L, Polman CH, Freedman MS, et al.

qes-llc.com/wp-content/uploads/2015/02/Vellturo_CV_last-four-years.pdf

12255-NMG. ▫ Bayer Pharma AG, Bayer Intellectual Property GMBH and Bayer Healthcare Pharmaceuticals, INC. v. ... Teva Pharmaceuticals USA, Inc., et al. and Sun Pharmaceuticals ... Apotex Inc. and Apotex Corp.; Hoffmann-LaRoche Inc. v.